IDEAS home Printed from https://ideas.repec.org/a/eee/hepoli/v126y2022i9p879-888.html
   My bibliography  Save this article

Should we screen for lung cancer? A 10-country analysis identifying key decision-making factors

Author

Listed:
  • Poon, Charlotte
  • Haderi, Artes
  • Roediger, Alexander
  • Yuan, Megan

Abstract

The need for early detection, both early diagnosis and screening is essential for improved prognosis in lung cancer. The effectiveness of lung cancer screening using low-dose computed tomography (LDCT) for high-risk patients has been shown by extensive clinical evidence including the National Lung Cancer Screening Trial (NLST) and the Dutch-Belgian lung cancer screening trial (NELSON) which has triggered political consideration of a formal programme across countries. However, implementation of these is still limited. This study investigates how governments make decisions on the implementation of lung cancer screening, identifying key consideration factors through 10 case study countries: Australia, Canada, Croatia, France, Germany, Japan, South Korea, Switzerland, UK, and US. We identified five decision-making factors (1) recognition of the disease burden and the value of early detection, (2) strong clinical data showing mortality reduction and benefit-risk analysis relevant to the local context, (3) cost-effectiveness data and budget impact, (4) local feasibility demonstration and (5) a clear and integrated decision-making mechanism involving relevant stakeholders. The set of factors identified in this paper can help advocates address knowledge gaps, identify the key focus areas for discussions with policymakers evaluating the opportunities for lung cancer screening programmes in their local context. Ultimately, this should allow policymakers to make more informed decisions on lung cancer screening to best improve lung cancer outcomes.

Suggested Citation

  • Poon, Charlotte & Haderi, Artes & Roediger, Alexander & Yuan, Megan, 2022. "Should we screen for lung cancer? A 10-country analysis identifying key decision-making factors," Health Policy, Elsevier, vol. 126(9), pages 879-888.
    • Handle: RePEc:eee:hepoli:v:126:y:2022:i:9:p:879-888
    DOI: 10.1016/j.healthpol.2022.06.003
    as

    Download full text from publisher

    File URL: http://www.sciencedirect.com/science/article/pii/S0168851022001555
    Download Restriction: Full text for ScienceDirect subscribers only
    File URL: https://libkey.io/10.1016/j.healthpol.2022.06.003?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Milan M. S. Obradović & Baptiste Hamelin & Nenad Manevski & Joana Pinto Couto & Atul Sethi & Marie-May Coissieux & Simone Münst & Ryoko Okamoto & Hubertus Kohler & Alexander Schmidt & Mohamed Bentires, 2019. "Glucocorticoids promote breast cancer metastasis," Nature, Nature, vol. 567(7749), pages 540-544, March.
    2. Xiujin Wu & Wenhua Zeng & Lvqing Yang & Jianbing Xiahou & Jinsheng Lu & Fan Lin & Fan Lin & Jianbing Xiahou & Shixuan Xie & Shixuan Xie, 2019. "Breast Cancer Category Based on Multi-View Clustering," Biomedical Journal of Scientific & Technical Research, Biomedical Research Network+, LLC, vol. 18(2), pages 13376-13381, May.
    3. Lynne F Forrest & Jean Adams & Helen Wareham & Greg Rubin & Martin White, 2013. "Socioeconomic Inequalities in Lung Cancer Treatment: Systematic Review and Meta-Analysis," PLOS Medicine, Public Library of Science, vol. 10(2), pages 1-25, February.
    4. François Bertucci & Charlotte K. Y. Ng & Anne Patsouris & Nathalie Droin & Salvatore Piscuoglio & Nadine Carbuccia & Jean Charles Soria & Alicia Tran Dien & Yahia Adnani & Maud Kamal & Séverine Garnie, 2019. "Genomic characterization of metastatic breast cancers," Nature, Nature, vol. 569(7757), pages 560-564, May.
    5. Lydia W. S. Finley, 2019. "Metabolic signal curbs cancer-cell migration," Nature, Nature, vol. 571(7763), pages 39-40, July.
    6. Paul A. Stewart & Eric A. Welsh & Robbert J. C. Slebos & Bin Fang & Victoria Izumi & Matthew Chambers & Guolin Zhang & Ling Cen & Fredrik Pettersson & Yonghong Zhang & Zhihua Chen & Chia-Ho Cheng & Ra, 2019. "Proteogenomic landscape of squamous cell lung cancer," Nature Communications, Nature, vol. 10(1), pages 1-17, December.
    7. Cheng-Hsueh Lee & Lih-Chyang Chen & Chia-Cheng Yu & Wen-Hsin Lin & Victor C. Lin & Chao-Yuan Huang & Te-Ling Lu & Shu-Pin Huang & Bo-Ying Bao, 2019. "Prognostic Value of CD1B in Localised Prostate Cancer," IJERPH, MDPI, vol. 16(23), pages 1-8, November.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Jennifer G. Abelin & Erik J. Bergstrom & Keith D. Rivera & Hannah B. Taylor & Susan Klaeger & Charles Xu & Eva K. Verzani & C. Jackson White & Hilina B. Woldemichael & Maya Virshup & Meagan E. Olive &, 2023. "Workflow enabling deepscale immunopeptidome, proteome, ubiquitylome, phosphoproteome, and acetylome analyses of sample-limited tissues," Nature Communications, Nature, vol. 14(1), pages 1-22, December.
    2. Domantas Jasilionis & Giedre Smailyte & Ieva Vincerzevskiene & Vladimir Shkolnikov, 2015. "Educational differentials in cancer mortality and avoidable deaths in Lithuania, 2001–2009: a census-linked study," International Journal of Public Health, Springer;Swiss School of Public Health (SSPH+), vol. 60(8), pages 919-926, December.
    3. Ajay Mahal & Lainie Sutton, 2014. "Economic prosperity and non-communicable disease: understanding the linkages," Chapters, in: Raghbendra Jha & Raghav Gaiha & Anil B. Deolalikar (ed.), Handbook on Food, chapter 12, pages 278-324, Edward Elgar Publishing.
    4. Mitrică, Bianca & Damian, Nicoleta & Grigorescu, Ines & Mocanu, Irena & Dumitraşcu, Monica & Persu, Mihaela, 2022. "Out-migration and social and technological marginalization in Romania. Regional disparities," Technological Forecasting and Social Change, Elsevier, vol. 175(C).
    5. Shengli Li & Li Yuan & Zhi-Yuan Xu & Jing-Li Xu & Gui-Ping Chen & Xiaoqing Guan & Guang-Zhao Pan & Can Hu & Jinyun Dong & Yi-An Du & Li-Tao Yang & Mao-Wei Ni & Rui-Bin Jiang & Xiu Zhu & Hang Lv & Han-, 2023. "Integrative proteomic characterization of adenocarcinoma of esophagogastric junction," Nature Communications, Nature, vol. 14(1), pages 1-19, December.
    6. Pousette, Andreas & Hofmarcher, Thomas, 2024. "Tackling inequalities in cancer care in the European Union," IHE Report / IHE Rapport 2024:1, IHE - The Swedish Institute for Health Economics.
    7. Jui-Kun Chiang & Yee-Hsin Kao & Ning-Sheng Lai, 2015. "The Impact of Hospice Care on Survival and Healthcare Costs for Patients with Lung Cancer: A National Longitudinal Population-Based Study in Taiwan," PLOS ONE, Public Library of Science, vol. 10(9), pages 1-19, September.
    8. Antonio Rodriguez-Calero & John Gallon & Dilara Akhoundova & Sina Maletti & Alison Ferguson & Joanna Cyrta & Ursula Amstutz & Andrea Garofoli & Viola Paradiso & Scott A. Tomlins & Ekkehard Hewer & Ver, 2022. "Alterations in homologous recombination repair genes in prostate cancer brain metastases," Nature Communications, Nature, vol. 13(1), pages 1-10, December.
    9. Shideh Mirhadi & Shirley Tam & Quan Li & Nadeem Moghal & Nhu-An Pham & Jiefei Tong & Brian J. Golbourn & Jonathan R. Krieger & Paul Taylor & Ming Li & Jessica Weiss & Sebastiao N. Martins-Filho & Vibh, 2022. "Integrative analysis of non-small cell lung cancer patient-derived xenografts identifies distinct proteotypes associated with patient outcomes," Nature Communications, Nature, vol. 13(1), pages 1-17, December.
    10. Klaas H J Ultee & Elke K M Tjeertes & Frederico Bastos Gonçalves & Ellen V Rouwet & Anton G M Hoofwijk & Robert Jan Stolker & Hence J M Verhagen & Sanne E Hoeks, 2018. "The relation between household income and surgical outcome in the Dutch setting of equal access to and provision of healthcare," PLOS ONE, Public Library of Science, vol. 13(1), pages 1-13, January.
    11. Aditya Bardia & Sarat Chandarlapaty & Hannah M. Linden & Gary A. Ulaner & Alice Gosselin & Sylvaine Cartot-Cotton & Patrick Cohen & Séverine Doroumian & Gautier Paux & Marina Celanovic & Vasiliki Pele, 2022. "AMEERA-1 phase 1/2 study of amcenestrant, SAR439859, in postmenopausal women with ER-positive/HER2-negative advanced breast cancer," Nature Communications, Nature, vol. 13(1), pages 1-15, December.
    12. Jianjie Li & Xiaodong Shu & Jun Xu & Sek Man Su & Un In Chan & Lihua Mo & Jianlin Liu & Xin Zhang & Ragini Adhav & Qiang Chen & Yuqing Wang & Tingting An & Xu Zhang & Xueying Lyu & Xiaoling Li & Josh , 2022. "S100A9-CXCL12 activation in BRCA1-mutant breast cancer promotes an immunosuppressive microenvironment associated with resistance to immunotherapy," Nature Communications, Nature, vol. 13(1), pages 1-19, December.
    13. Yael Aylon & Noa Furth & Giuseppe Mallel & Gilgi Friedlander & Nishanth Belugali Nataraj & Meng Dong & Ori Hassin & Rawan Zoabi & Benjamin Cohen & Vanessa Drendel & Tomer Meir Salame & Saptaparna Mukh, 2022. "Breast cancer plasticity is restricted by a LATS1-NCOR1 repressive axis," Nature Communications, Nature, vol. 13(1), pages 1-20, December.
    14. S. Mouron & M. J. Bueno & A. Lluch & L. Manso & I. Calvo & J. Cortes & J. A. Garcia-Saenz & M. Gil-Gil & N. Martinez-Janez & J. V. Apala & E. Caleiras & Pilar Ximénez-Embún & J. Muñoz & L. Gonzalez-Co, 2022. "Phosphoproteomic analysis of neoadjuvant breast cancer suggests that increased sensitivity to paclitaxel is driven by CDK4 and filamin A," Nature Communications, Nature, vol. 13(1), pages 1-18, December.
    15. Maheswaran, Hendramoorthy & Kupek, Emil & Petrou, Stavros, 2015. "Self-reported health and socio-economic inequalities in England, 1996–2009: Repeated national cross-sectional study," Social Science & Medicine, Elsevier, vol. 136, pages 135-146.
    16. Jorge Gómez Tejeda Zañudo & Romualdo Barroso-Sousa & Esha Jain & Qingchun Jin & Tianyu Li & Jorge E. Buendia-Buendia & Alyssa Pereslete & Daniel L. Abravanel & Arlindo R. Ferreira & Eileen Wrabel & Ka, 2024. "Exemestane plus everolimus and palbociclib in metastatic breast cancer: clinical response and genomic/transcriptomic determinants of resistance in a phase I/II trial," Nature Communications, Nature, vol. 15(1), pages 1-19, December.
    17. Jian Ma & Lei Li & Bohan Ma & Tianjie Liu & Zixi Wang & Qi Ye & Yunhua Peng & Bin Wang & Yule Chen & Shan Xu & Ke Wang & Fabin Dang & Xinyang Wang & Zixuan Zeng & Yanlin Jian & Zhihua Ren & Yizeng Fan, 2024. "MYC induces CDK4/6 inhibitors resistance by promoting pRB1 degradation," Nature Communications, Nature, vol. 15(1), pages 1-16, December.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:hepoli:v:126:y:2022:i:9:p:879-888. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu or the person in charge (email available below). General contact details of provider: http://www.elsevier.com/locate/healthpol .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.